Fredun Pharmaceuticals fundamental analysis

FREDUN

1692

24.20 (-1.41%)
Last updated on 24 Dec, 2025 | 15:29 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Fredun Pharmaceuticals Fundamentals

P/E Ratio

41.93

P/B Ratio

5.26

Div. Yield

0.04

Sector P/E

71.29

Sector P/B

1.1

Sec. Div. Yield

0.56

Fredun Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 41.93, compared to the sector average of 71.29. Its P/B Ratio stands at 5.26, while the sector’s is 1.1. In terms of returns, the stock offers a Dividend Yield of 0.04%, which is than the sector’s 0.56%.

Fredun Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Average

  • quality_check
    Management

    Good

On its scorecard, Fredun Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.